These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7558438)

  • 1. Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid.
    Hill SA; Sampson LE; Chaplin DJ
    Int J Cancer; 1995 Sep; 63(1):119-23. PubMed ID: 7558438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of mitomycin-C cytotoxicity by combination with flavone acetic acid in a murine tumour.
    Parkins CS; Denekamp J; Chaplin DJ
    Anticancer Res; 1993; 13(5A):1437-42. PubMed ID: 8239516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of chlorambucil cytotoxicity by combination with flavone acetic acid in a murine tumour.
    Parkins CS; Chadwick JA; Chaplin DJ
    Anticancer Res; 1994; 14(4A):1603-8. PubMed ID: 7979193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action.
    Hill S; Williams KB; Denekamp J
    Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1419-24. PubMed ID: 2591434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents.
    Chaplin DJ; Pettit GR; Parkins CS; Hill SA
    Br J Cancer Suppl; 1996 Jul; 27():S86-8. PubMed ID: 8763854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinca alkaloids: anti-vascular effects in a murine tumour.
    Hill SA; Lonergan SJ; Denekamp J; Chaplin DJ
    Eur J Cancer; 1993; 29A(9):1320-4. PubMed ID: 8343277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavone acetic acid induces a coagulopathy in mice.
    Murray JC; Smith KA; Thurston G
    Br J Cancer; 1989 Nov; 60(5):729-33. PubMed ID: 2803949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.
    Baguley BC; Zhuang L; Kestell P
    Oncol Res; 1997; 9(2):55-60. PubMed ID: 9167186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
    Thomsen LL; Baguley BC; Wilson WR
    Cancer Chemother Pharmacol; 1992; 31(2):151-5. PubMed ID: 1451234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant treatment does not affect the action of flavone acetic acid in tumour-bearing mice.
    Thurston G; Smith KA; Murray JC
    Br J Cancer; 1991 Oct; 64(4):689-92. PubMed ID: 1911218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor-alpha plasma levels after flavone acetic acid administration in man and mouse.
    Chabot GG; Branellec D; Sassi A; Armand JP; Gouyette A; Chouaib S
    Eur J Cancer; 1993; 29A(5):729-33. PubMed ID: 8471332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavone acetic acid potentiates the induction of endothelial procoagulant activity by tumour necrosis factor.
    Murray JC; Smith KA; Stern DM
    Eur J Cancer; 1991; 27(6):765-70. PubMed ID: 1829921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.
    Bibby MC; Phillips RM; Double JA; Pratesi G
    Br J Cancer; 1991 Jan; 63(1):57-62. PubMed ID: 1989665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoacting agents flavone acetic acid and hydralazine given in combination enhance antitumor effects under condition of hyperthermia.
    Yamamoto M; Kusumoto T; Endo K; Baba H; Sakaguchi Y; Maehara Y; Sugimachi K
    Oncology; 1996; 53(2):147-52. PubMed ID: 8604241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512).
    Bibby MC; Phillips RM; Double JA
    Cancer Chemother Pharmacol; 1989; 24(2):87-94. PubMed ID: 2731316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma.
    Sun JR; Brown JM
    Cancer Res; 1989 Oct; 49(20):5664-70. PubMed ID: 2790784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acid.
    Pratesi G; Rodolfo M; Rovetta G; Parmiani G
    Eur J Cancer; 1990; 26(10):1079-83. PubMed ID: 2148884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo interaction between flavone acetic acid and hyperthermia.
    Horsman MR; Sampson LE; Chaplin DJ; Overgaard J
    Int J Hyperthermia; 1996; 12(6):779-89. PubMed ID: 8950158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin involvement in the antitumour and host effects of flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
    Baguley BC; Cole G; Thomsen LL; Li Z
    Cancer Chemother Pharmacol; 1993; 33(1):77-81. PubMed ID: 8269593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice.
    Chabot GG; Bissery MC; Corbett TH; Rutkowski K; Baker LH
    Cancer Chemother Pharmacol; 1989; 24(1):15-22. PubMed ID: 2597279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.